#BEGIN_DRUGCARD DB01702

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
102-32-9

# ChEBI_ID:
1386

# Chemical_Formula:
C8H8O4

# Chemical_IUPAC_Name:
2-(3,4-dihydroxyphenyl)acetic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A deaminated metabolite of levodopa. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
0.98

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-(3,4-Dihydroxyphenyl)Acetic Acid

# HET_ID:
DHY

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)

# InChI_Key:
InChIKey=CFFZDZCDUFSOFZ-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C01161

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1702

# Mechanism_Of_Action:
Not Available

# Melting_Point:
128.5 °C

# Molecular_Weight_Avg:
168.1467

# Molecular_Weight_Mono:
168.042258744

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1F1V

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.93

# Predicted_LogS:
-1.4

# Predicted_Water_Solubility:
7.23e+00 g/l

# Primary_Accession_No:
DB01702

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
547

# PubChem_Substance_ID:
46507886

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01200
EXPT01685

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)CC1=CC(O)=C(O)C=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:24 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
4.25 (at 30 °C)

# Drug_Target_1_Cellular_Location:
Nucleus and mitochondria

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>Example: Dickerson dodecamer
CGCGAATTCGCG

# Drug_Target_1_General_Function:
Biological information storage and information transfer

# Drug_Target_1_General_References:
1234	Nadeau D, Marchand C: Change in the kinetics of sulphacetamide tissue distribution in Walker tumor-bearing rats. Drug Metab Dispos. 1975 Nov-Dec;3(6):565-76.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
874

# Drug_Target_1_Locus:
All loci

# Drug_Target_1_Molecular_Weight:
7656 (double strand)

# Drug_Target_1_Name:
DNA

# Drug_Target_1_Number_of_Residues:
0

# Drug_Target_1_PDB_ID:
1BNA

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
Not Available

# Drug_Target_1_Protein_Sequence:
Not Available

# Drug_Target_1_Reaction:
DNA + DNA polymerase + nNTP = 2 DNA + nNDP; DNA + RNA polymerase + NTP = mRNA + nNDP

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
DNA is the molecule of heredity, as it is responsible for the genetic propagation of most inherited traits. It is a polynucleic acid that carries genetic information on cell growth, division, and function. DNA consists of two long strands of nucleotides twisted into a double helix and held together by hydrogen bonds. The sequence of nucleotides determines hereditary characteristics. Each strand serves as the template for subsequent DNA replication and as a template for mRNA production, leading to protein synthesis via ribosomes.

# Drug_Target_1_SwissProt_ID:
Not Available

# Drug_Target_1_SwissProt_Name:
Not Available

# Drug_Target_1_Synonyms:
Deoxyribonucleic acid

# Drug_Target_1_Theoretical_pI:
Not Available

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
U19817

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
mndD

# Drug_Target_2_Gene_Sequence:
>1032 bp
ATGACCAACTTCGTTCCCACCCCCTCTGTCCCGGCACCGGATATCGTCCGCTGCGCCTAC
ATGGAGATCGTGGTCACGGACCTCGCCAAGTCGCGCGAGTTCTACGTGGACGTCCTGGGC
CTGCACGTCACCGAAGAGGATGAAAACACCATCTACCTCCGCTCCCTGGAGGAGTTCATC
CACCACAACCTGGTACTCCGCCAGGGACCCATCGCCGCCGTCGCAGCCTTCGCCTACCGG
GTGAAGTCCCCCGCCGAGGTGGATGCCGCCGAGGCGTACTACAAGGAGCTGGGCTGCCGC
ACCGAGCGCCGCAAGGAAGGCTTCACCAAGGGCATCGGCGACTCCGTCCGCGTCGAGGAC
CCGCTGGGCTTCCCCTACGAGTTCTTCTACGAGACCGAGCACGTGGAGCGCCTCACCCAG
CGCTACGACCTCTACTCCGCCGGTGAACTGGTGCGCCTGGACCACTTCAACCAGGTCACC
CCGGACGTTCCCCGCGGCCGGGCGTACCTGGAGGACCTCGGCTTCCGCGTCTCCGAAGAC
ATCAAGGACTCCGACGGCGTCACCTACGCCGCCTGGATGCACCGCAAGCAGACCGTGCAC
GACACCGCCCTGACCGGCGGCAACGGCCCGCGCATGCACCACGTCGCGTTCGCCACGCAC
GAGAAGCACAACATCATCCAGATCTGCGACAAGATGCGGCCCTGCGCATCAGCGACCGGA
TCGAACGGCCCCCGGCCGGCACCGGTCTCCAACGCCTTCTACCTCTACATCCTGGACCCG
GACGGCCACCGCATCGAGATCTACACCCAGGACTACTACACCGGCGACCCGGACAACCCC
ACCATCACCTGGGACGTCCACGACAACCAGCGCCGCGACTGGTGGGGCAACCCCGTGGTC
CCGTCCTGGTACACCGAGGCCTCCCTGGTCCTGGACCTGGACGGCAACCCGCAGCCGGTC
ATCGTCCGCGAGGAAAAGTCCGAAATGGCCGTGACCGTCGGAGCCGAGCCTTCTCCTACA
CCCGCAAGATGA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
7868595	Boldt YR, Sadowsky MJ, Ellis LB, Que L Jr, Wackett LP: A manganese-dependent dioxygenase from Arthrobacter globiformis CM-2 belongs to the major extradiol dioxygenase family. J Bacteriol. 1995 Mar;177(5):1225-32.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4298

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
38862

# Drug_Target_2_Name:
3,4-dihydroxyphenylacetate 2,3-dioxygenase

# Drug_Target_2_Number_of_Residues:
343

# Drug_Target_2_PDB_ID:
1F1V

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00903	Glyoxalase

# Drug_Target_2_Protein_Sequence:
>3,4-dihydroxyphenylacetate 2,3-dioxygenase
MTNFVPTPSVPAPDIVRCAYMEIVVTDLAKSREFYVDVLGLHVTEEDENTIYLRSLEEFI
HHNLVLRQGPIAAVAAFAYRVKSPAEVDAAEAYYKELGCRTERRKEGFTKGIGDSVRVED
PLGFPYEFFYETEHVERLTQRYDLYSAGELVRLDHFNQVTPDVPRGRAYLEDLGFRVSED
IKDSDGVTYAAWMHRKQTVHDTALTGGNGPRMHHVAFATHEKHNIIQICDKMRPCASATG
SNGPRPAPVSNAFYLYILDPDGHRIEIYTQDYYTGDPDNPTITWDVHDNQRRDWWGNPVV
PSWYTEASLVLDLDGNPQPVIVREEKSEMAVTVGAEPSPTPAR

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q44048

# Drug_Target_2_SwissProt_Name:
Q44048_ARTGO

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
4.88

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
U58132

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
Not Available

# Drug_Target_3_Gene_Sequence:
>1098 bp
ATGAGCAACGAAATCCCCAAGCCAGTCGCACCAGCACCGGATATCCTGCGCTGCGCCTAC
GCCGAACTGGTCGTCACCGACCTGGCCAAGTCCCGCAACTTCTACGTGGACGTCCTGGGC
CTGCACGTATCCTACGAGGACGAGAACCAGATCTACCTGCGCTCCTTCGAGGAGTTCATC
CACCACAACCTGGTCCTGACCAAGGGTCCGGTCGCCGCGCTGAAGGCCATGGCATTCCGC
GTGCGCACCCCTGAGGACGTCGACAAGGCCGAGGCCTACTACCAGGAGCTGGGCTGCCGC
ACCGAGCGCCGCAAGGACGGCTTCGTCAAGGGCATCGGCGACGCCCTGCGCGTGGAGGAT
CCGCTGGGCTTCCCGTACGAGTTCTTCTTCGAGACCACCCACGTCGAACGCCTGCACATG
CGCTACGACCTGTACTCGGCCGGCGAACTGGTCCGCCTGGACCACTTCAACCAGGTGACC
CCGGACGTGCCGCGCGGCCGCAAGTACCTCGAGGACCTGGGCTTCCGCGTCACCGAGGAC
ATCCAGGACGATGAGGGCACCACCTACGCAGCCTGGATGCACCGCAAGGGCACCGTGCAC
GACACCGCCCTGACCGGCGGCAACGGCCCGCGCCTGCACCACGTGGCCTTCTCCACCCAT
GAGAAGCACAACATCATCCAGATCTGCGACAAGATGGGCGCCCTGCGCATCTCGGACCGG
ATCGAGCGCGGCCCGGGCCGCCACGGCGTCTCCAACGCGTTCTACCTGTACATCCTGGAT
CCGGACAACCACCGCATCGAGATCTACACCCAGGACTACTACACCGGCGACCCGGACAAC
CCGACCATCACCTGGAACGTCCACGACAACCAGCGCCGCGACTGGTGGGGCAACCCGGTT
GTGCCTTCGTGGTACACCGAGGCCTCCAAGGTCCTGGACCTGGACGGCAACGTGCAGGAG
ATCATCGAGCGCACCGACGACTCCGAACTGGAAGTCACCATCGGCGCCGACGGCTTCTCC
TTCACCCGCGCGGGCGACGAGGACGGCTCGTACCACGGCCAGGCTTCGAAGGGCTTCAAG
CTGGGCAACCAGCTCTAG

# Drug_Target_3_General_Function:
Amino acid transport and metabolism

# Drug_Target_3_General_References:
9179284	Wang YZ, Lipscomb JD: Cloning, overexpression, and mutagenesis of the gene for homoprotocatechuate 2,3-dioxygenase from Brevibacterium fuscum. Protein Expr Purif. 1997 Jun;10(1):1-9.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
4299

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
41700

# Drug_Target_3_Name:
Homoprotocatechuate 2,3-dioxygenase

# Drug_Target_3_Number_of_Residues:
365

# Drug_Target_3_PDB_ID:
1Q0O

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00903	Glyoxalase

# Drug_Target_3_Protein_Sequence:
>Homoprotocatechuate 2,3-dioxygenase
MSNEIPKPVAPAPDILRCAYAELVVTDLAKSRNFYVDVLGLHVSYEDENQIYLRSFEEFI
HHNLVLTKGPVAALKAMAFRVRTPEDVDKAEAYYQELGCRTERRKDGFVKGIGDALRVED
PLGFPYEFFFETTHVERLHMRYDLYSAGELVRLDHFNQVTPDVPRGRKYLEDLGFRVTED
IQDDEGTTYAAWMHRKGTVHDTALTGGNGPRLHHVAFSTHEKHNIIQICDKMGALRISDR
IERGPGRHGVSNAFYLYILDPDNHRIEIYTQDYYTGDPDNPTITWNVHDNQRRDWWGNPV
VPSWYTEASKVLDLDGNVQEIIERTDDSELEVTIGADGFSFTRAGDEDGSYHGQASKGFK
LGNQL

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
Q45135

# Drug_Target_3_SwissProt_Name:
Q45135_9MICO

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
5.08

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Periplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_4_Essentiality:
Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
M15950

# Drug_Target_4_GenBank_ID_Protein:
147063

# Drug_Target_4_GeneCard_ID:
pac

# Drug_Target_4_Gene_Name:
pac

# Drug_Target_4_Gene_Sequence:
Not Available

# Drug_Target_4_General_Function:
Involved in calcium ion binding

# Drug_Target_4_General_References:
11601852	McVey CE, Walsh MA, Dodson GG, Wilson KS, Brannigan JA: Crystal structures of penicillin acylase enzyme-substrate complexes: structural insights into the catalytic mechanism. J Mol Biol. 2001 Oct 12;313(1):139-50.
1849824	Slade A, Horrocks AJ, Lindsay CD, Dunbar B, Virden R: Site-directed chemical conversion of serine to cysteine in penicillin acylase from Escherichia coli ATCC 11105. Effect on conformation and catalytic activity. Eur J Biochem. 1991 Apr 10;197(1):75-80.
2205499	Sizmann D, Keilmann C, Bock A: Primary structure requirements for the maturation in vivo of penicillin acylase from Escherichia coli ATCC 11105. Eur J Biochem. 1990 Aug 28;192(1):143-51.
2989404	Bruns W, Hoppe J, Tsai H, Bruning HJ, Maywald F, Collins J, Mayer H: Structure of the penicillin acylase gene from Escherichia coli: a periplasmic enzyme that undergoes multiple proteolytic processing. J Mol Appl Genet. 1985;3(1):36-44.
3005131	Oliver G, Valle F, Rosetti F, Gomez-Pedrozo M, Santamaria P, Gosset G, Bolivar F: A common precursor for the two subunits of the penicillin acylase from Escherichia coli ATCC11105. Gene. 1985;40(1):9-14.
3016663	Schumacher G, Sizmann D, Haug H, Buckel P, Bock A: Penicillin acylase from E. coli: unique gene-protein relation. Nucleic Acids Res. 1986 Jul 25;14(14):5713-27.
3315861	Oh SJ, Kim YC, Park YW, Min SY, Kim IS, Kang HS: Complete nucleotide sequence of the penicillin G acylase gene and the flanking regions, and its expression in Escherichia coli. Gene. 1987;56(1):87-97.
3556321	Valle F, Gosset G, Tenorio B, Oliver G, Bolivar F: Characterization of the regulatory region of the Escherichia coli penicillin acylase structural gene. Gene. 1986;50(1-3):119-22.
7816145	Duggleby HJ, Tolley SP, Hill CP, Dodson EJ, Dodson G, Moody PC: Penicillin acylase has a single-amino-acid catalytic centre. Nature. 1995 Jan 19;373(6511):264-8.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
6308

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
94642.0

# Drug_Target_4_Name:
Penicillin G acylase

# Drug_Target_4_Number_of_Residues:
846

# Drug_Target_4_PDB_ID:
1E3A

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01804	Penicil_amidase

# Drug_Target_4_Protein_Sequence:
>Penicillin G acylase
MKNRNRMIVNCVTASLMYYWSLPALAEQSSSEIKIVRDEYGMPHIYANDTWHLFYGYGYV
VAQDRLFQMEMARRSTQGTVAEVLGKDFVKFDKDIRRNYWPDAIRAQIAALSPEDMSILQ
GYADGMNAWIDKVNTNPETLLPKQFNTFGFTPKRWEPFDVAMIFVGTMANRFSDSTSEID
NLALLTALKDKYGVSQGMAVFNQLKWLVNPSAPTTIAVQESNYPLKFNQQNSQTAALLPR
YDLPAPMLDRPAKGADGALLALTAGKNRETIAAQFAQGGANGLAGYPTTSNMWVIGKSKA
QDAKAIMVNGPQFGWYAPAYTYGIGLHGAGYDVTGNTPFAYPGLVFGHNGVISWGSTAGF
GDDVDIFAERLSAEKPGYYLHNGKWVKMLSREETITVKNGQAETFTVWRTVHGNILQTDQ
TTQTAYAKSRAWDGKEVASLLAWTHQMKAKNWQEWTQQAAKQALTINWYYADVNGNIGYV
HTGAYPDRQSGHDPRLPVPGTGKWDWKGLLPFEMNPKVYNPQSGYIANWNNSPQKDYPAS
DLFAFLWGGADRVTEIDRLLEQKPRLTADQAWDVIRQTSRQDLNLRLFLPTLQAATSGLT
QSDPRRQLVETLTRWDGINLLNDDGKTWQQPGSAILNVWLTSMLKRTVVAAVPMPFDKWY
SASGYETTQDGPTGSLNISVGAKILYEAVQGDKSPIPQAVDLFAGKPQQEVVLAALEDTW
ETLSKRYGNNVSNWKTPAMALTFRANNFFGVPQAAAEETRHQAEYQNRGTENDMIVFSPT
TSDRPVLAWDVVAPGQSGFIAPDGTVDKHYEDQLKMYENFGRKSLWLTKQDVEAHKESQE
VLHVQR

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
1-26

# Drug_Target_4_Specific_Function:
Penicillin + H(2)O = a carboxylate + 6- aminopenicillanate

# Drug_Target_4_SwissProt_ID:
P06875

# Drug_Target_4_SwissProt_Name:
PAC_ECOLX

# Drug_Target_4_Synonyms:
Penicillin G acylase subunit alpha
Penicillin G acylase subunit beta
Penicillin G amidase
Penicillin G amidohydrolase

# Drug_Target_4_Theoretical_pI:
6.59

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_5_Essentiality:
Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
L14836

# Drug_Target_5_GenBank_ID_Protein:
294344

# Drug_Target_5_GeneCard_ID:
pcaG

# Drug_Target_5_Gene_Name:
pcaG

# Drug_Target_5_Gene_Sequence:
>720 bp
ATGCCCGCCCAGGACAACAGCCGCTTCGTGATCCGTGATCGCAACTGGCACCCCAAAGCC
CTTACGCCTGACTACAAAACGTCCATTGCCCGCTCGCCGCGCCAGGCACTGGTCAGCATT
CCACAGTCGATCAGCGAAACCACTGGTCCGAACTTTTCCCACCTGGGCTTCGGCGCCCAC
GACCATGACCTGCTGCTGAACTTCAACAACGGTGGCCTGCCAATCGGCGAGCGCATCATC
GTGGCCGGCCGCGTCGTCGACCAGTACGGCAAGCCTGTGCCGAACACCCTGGTGGAGATG
TGGCAAGCCAACGCCGGTGGCCGCTACCGGCACAAGAACGACCGTTACCTGGCACCGCTG
GACCCGAACTTTGGTGGTGTCGGCCGTTGCCTGACCGACAGCGACGGCTACTACAGCTTC
CGCACCATCAAGCCGGGCCCGTACCCCTGGCGCAACGGCCCGAACGACTGGCGCCCGGCG
CACATCCACTTCGGCATCAGCGGCCCGTCGATTGCGACCAAGCTGATCACCCAGTTGTAT
TTCGAGGGTGACCCGCTGATCCCGATGTGCCCGATCGTCAAGTCGATCGCCAACCCTGAA
GCTGTACAGCAGTTGATCGCCAAGCTCGACATGAACAACGCCAACCCGATGGACTGCCTG
GCCTACCGCTTTGACATCGTGCTGCGCGGCCAGCGCAAGACCCACTTCGAAAACTGCTGA

# Drug_Target_5_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_5_General_References:
3194022	Ohlendorf DH, Lipscomb JD, Weber PC: Structure and assembly of protocatechuate 3,4-dioxygenase. Nature. 1988 Nov 24;336(6197):403-5.
465136	Kohlmiller NA, Howard JB: The primary structure of the alpha subunit of protocatechuate 3,4-dioxygenase. II. Isolation and sequence of overlap peptides and complete sequence. J Biol Chem. 1979 Aug 10;254(15):7309-15.
7990141	Ohlendorf DH, Orville AM, Lipscomb JD: Structure of protocatechuate 3,4-dioxygenase from Pseudomonas aeruginosa at 2.15 A resolution. J Mol Biol. 1994 Dec 16;244(5):586-608.
8407791	Frazee RW, Livingston DM, LaPorte DC, Lipscomb JD: Cloning, sequencing, and expression of the Pseudomonas putida protocatechuate 3,4-dioxygenase genes. J Bacteriol. 1993 Oct;175(19):6194-202.
9254599	Orville AM, Elango N, Lipscomb JD, Ohlendorf DH: Structures of competitive inhibitor complexes of protocatechuate 3,4-dioxygenase: multiple exogenous ligand binding orientations within the active site. Biochemistry. 1997 Aug 19;36(33):10039-51.
9254600	Orville AM, Lipscomb JD, Ohlendorf DH: Crystal structures of substrate and substrate analog complexes of protocatechuate 3,4-dioxygenase: endogenous Fe3+ ligand displacement in response to substrate binding. Biochemistry. 1997 Aug 19;36(33):10052-66.
9298971	Elgren TE, Orville AM, Kelly KA, Lipscomb JD, Ohlendorf DH, Que L Jr: Crystal structure and resonance Raman studies of protocatechuate 3,4-dioxygenase complexed with 3,4-dihydroxyphenylacetate. Biochemistry. 1997 Sep 23;36(38):11504-13.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
6537

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
22386.9

# Drug_Target_5_Name:
Protocatechuate 3,4-dioxygenase alpha chain

# Drug_Target_5_Number_of_Residues:
201

# Drug_Target_5_PDB_ID:
3PCN

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00775	Dioxygenase_C

# Drug_Target_5_Protein_Sequence:
>Protocatechuate 3,4-dioxygenase alpha chain
MPIELLPETPSQTAGPYVHIGLALEAAGNPTRDQEIWNRLAKPDAPGEHILLLGQVYDGN
GHLVRDSFLEVWQADANGEYQDAYNLENAFNSFGRTATTFDAGEWTLHTVKPGVVNNAAG
VPMAPHINISLFARGINIHLHTRLYFDDEAQANAKCPVLNLIEQPQRRETLIAKRCEVDG
KTAYRFDIRIQGEGETVFFDF

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Plays an essential role in the utilization of numerous aromatic and hydroaromatic compounds via the beta-ketoadipate pathway

# Drug_Target_5_SwissProt_ID:
P00436

# Drug_Target_5_SwissProt_Name:
PCXA_PSEPU

# Drug_Target_5_Synonyms:
3,4-PCD

# Drug_Target_5_Theoretical_pI:
4.77

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_6_Essentiality:
Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
L14836

# Drug_Target_6_GenBank_ID_Protein:
294344

# Drug_Target_6_GeneCard_ID:
pcaH

# Drug_Target_6_Gene_Name:
pcaH

# Drug_Target_6_Gene_Sequence:
>720 bp
ATGCCCGCCCAGGACAACAGCCGCTTCGTGATCCGTGATCGCAACTGGCACCCCAAAGCC
CTTACGCCTGACTACAAAACGTCCATTGCCCGCTCGCCGCGCCAGGCACTGGTCAGCATT
CCACAGTCGATCAGCGAAACCACTGGTCCGAACTTTTCCCACCTGGGCTTCGGCGCCCAC
GACCATGACCTGCTGCTGAACTTCAACAACGGTGGCCTGCCAATCGGCGAGCGCATCATC
GTGGCCGGCCGCGTCGTCGACCAGTACGGCAAGCCTGTGCCGAACACCCTGGTGGAGATG
TGGCAAGCCAACGCCGGTGGCCGCTACCGGCACAAGAACGACCGTTACCTGGCACCGCTG
GACCCGAACTTTGGTGGTGTCGGCCGTTGCCTGACCGACAGCGACGGCTACTACAGCTTC
CGCACCATCAAGCCGGGCCCGTACCCCTGGCGCAACGGCCCGAACGACTGGCGCCCGGCG
CACATCCACTTCGGCATCAGCGGCCCGTCGATTGCGACCAAGCTGATCACCCAGTTGTAT
TTCGAGGGTGACCCGCTGATCCCGATGTGCCCGATCGTCAAGTCGATCGCCAACCCTGAA
GCTGTACAGCAGTTGATCGCCAAGCTCGACATGAACAACGCCAACCCGATGGACTGCCTG
GCCTACCGCTTTGACATCGTGCTGCGCGGCCAGCGCAAGACCCACTTCGAAAACTGCTGA

# Drug_Target_6_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_6_General_References:
115853	Iwaki M, Kagamiyama H, Nozaki M: The complete amino acid sequence of the beta-subunit of protocatechuate 3,4-dioxygenase from Pseudomonas aeruginosa. J Biochem. 1979 Oct;86(4):1159-62.
3194022	Ohlendorf DH, Lipscomb JD, Weber PC: Structure and assembly of protocatechuate 3,4-dioxygenase. Nature. 1988 Nov 24;336(6197):403-5.
7990141	Ohlendorf DH, Orville AM, Lipscomb JD: Structure of protocatechuate 3,4-dioxygenase from Pseudomonas aeruginosa at 2.15 A resolution. J Mol Biol. 1994 Dec 16;244(5):586-608.
8407791	Frazee RW, Livingston DM, LaPorte DC, Lipscomb JD: Cloning, sequencing, and expression of the Pseudomonas putida protocatechuate 3,4-dioxygenase genes. J Bacteriol. 1993 Oct;175(19):6194-202.
9254599	Orville AM, Elango N, Lipscomb JD, Ohlendorf DH: Structures of competitive inhibitor complexes of protocatechuate 3,4-dioxygenase: multiple exogenous ligand binding orientations within the active site. Biochemistry. 1997 Aug 19;36(33):10039-51.
9254600	Orville AM, Lipscomb JD, Ohlendorf DH: Crystal structures of substrate and substrate analog complexes of protocatechuate 3,4-dioxygenase: endogenous Fe3+ ligand displacement in response to substrate binding. Biochemistry. 1997 Aug 19;36(33):10052-66.
9298971	Elgren TE, Orville AM, Kelly KA, Lipscomb JD, Ohlendorf DH, Que L Jr: Crystal structure and resonance Raman studies of protocatechuate 3,4-dioxygenase complexed with 3,4-dihydroxyphenylacetate. Biochemistry. 1997 Sep 23;36(38):11504-13.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
6538

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
26793.2

# Drug_Target_6_Name:
Protocatechuate 3,4-dioxygenase beta chain

# Drug_Target_6_Number_of_Residues:
239

# Drug_Target_6_PDB_ID:
3PCN

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00775	Dioxygenase_C

# Drug_Target_6_Protein_Sequence:
>Protocatechuate 3,4-dioxygenase beta chain
MPAQDNSRFVIRDRNWHPKALTPDYKTSIARSPRQALVSIPQSISETTGPNFSHLGFGAH
DHDLLLNFNNGGLPIGERIIVAGRVVDQYGKPVPNTLVEMWQANAGGRYRHKNDRYLAPL
DPNFGGVGRCLTDSDGYYSFRTIKPGPYPWRNGPNDWRPAHIHFGISGPSIATKLITQLY
FEGDPLIPMCPIVKSIANPEAVQQLIAKLDMNNANPMDCLAYRFDIVLRGQRKTHFENC

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Plays an essential role in the utilization of numerous aromatic and hydroaromatic compounds via the beta-ketoadipate pathway

# Drug_Target_6_SwissProt_ID:
P00437

# Drug_Target_6_SwissProt_Name:
PCXB_PSEPU

# Drug_Target_6_Synonyms:
3,4-PCD

# Drug_Target_6_Theoretical_pI:
9.12

# Drug_Target_6_Transmembrane_Regions:
None

#END_DRUGCARD DB01702
